Search
PEPR Quantique - Appel à projets Calcul Quantique au Vol
La stratégie nationale pour l’Accélération des Technologies Quantique , annoncée par le Président de la République le 21 janvier 2021, vise à guider les choix de l’État pour les cinq prochaines ann
Specific support for research works and innovation for defense: Maturation and Development (ASTRID-Maturation) (ASTRID Maturation) 2022
The French National Research Agency (ANR), in partnership with the French Defense Innovation Agency (AID) (attached to the defense procurement agency - DGA), has launched the 2022 ASTRID programme "Specific support for defence research works and innovation : Maturation and Development”. The programme is entirely funded by the AID and is implemented by ANR.
JPcofuND 2. Understanding the mechanisms of non-pharmacological intervention
The ANR launches in collaboration with the ERA-NET JPcofuND 2 a joint call to support multinational, collaborative research projects aiming at improving the understanding of the mechanisms and biological substrates that underlie non-pharmacological interventions in order to tailor a holistic personalized treatment approach. Several non-pharmacological interventions have been shown to be effective and accepted by the patients. Such interventions may include, among others, psychosocial interventions, neuromodulation, nutrition or exercise. However, there is yet little knowledge about the mechanisms of non-pharmacological interventions, e. g. on the molecular or cellular level.
Disrupting drug Resistance using Innovative Design (JPIAMR-DRUID)
The French National Research Agency, in partnership with seventeen countries (Belgium, Canada, Czech Republic, Denmark, Estonia, Germany, Hungary, Israel, Italy, Latvia, Lithuania, Moldova, Poland, Spain, Sweden, Switzerland, United Kingdom) is launching the fourteenth call for proposals under the umbrella of the JPIAMR. The initiative aims to promote international research on antimicrobial resistance. The total budget for this action is 18.9 million euros.
Multinational and translational research projects on Cerebrovascular Diseases including Small Vessels and Brain Barriers Dysfunction - ERA NET Neuron - 2022
The aim of the call is to fund multinational, collaborative research projects that will address important translational questions in the areas of stroke and other cerebrovascular diseases including small vessels disease (CSVD) and the dysfunction of brain barriers.
FRAL 2022 - Franco-German call for proposals in Humanities and Social Sciences
The ANR is launching its 16th Franco-German call for proposals in Humanities and Social Sciences (HSS) in collaboration with the Deutsche Forschungsgemeinschaft (DFG).
Development of new analytic tools and pathways to accelerate diagnosis and facilitate diagnostic monitoring of rare diseases EJP RD 2022
The 4th call for projects of EJP RD to fund multinational research projects on rare diseases will gather 21 countries (Australia, Austria, Belgium, Canada, Czech Republic, Finland, France, Germany, Hungary, Ireland, Israël, Italia, Lithuania, Luxemburg, the Netherlands, Poland, Slovakia, Sweden, Spain, Switzerland, Turkey).
Specific Support for Defence Research Projects and Innovation (ASTRID) - 2022
The French National Research Agency (ANR), in partnership with the French Defense innovation Agency (AID) and Armaments Procurement Agency (DGA), has launched the 2022 ASTRID programme, providing "specific support for defence research projects and innovation". The programme is entirely funded by the AID and implemented by ANR.
12th Call of the CHIST-ERA ERA-NET
The ANR participates in the 12th call of the CHIST-ERA ERA-NET consortium (European coordinated research on long-term ICT and ICT-based scientific Challenges) bringing together 18 countries, with a budget of 10,2 M€.
Joint transnational call 2022 for proposals on Personalised Medicine through the ERA-NET: ERA PerMed
The French National Research Agency, in partnership with 33 funding organisations of 26 countries launches the fifth joint transnational call for proposals on “Prevention in Personalised Medicine” through the ERA-NET ERA PerMed. The available budget for this call is 29 Mio€ (approx.).